Astria Therapeutics Inc.

12/11/2024 | Press release | Distributed by Public on 12/11/2024 07:13

Astria Therapeutics Announces Positive Final Results from Target Enrollment in the ALPHA-STAR Phase 1b/2 Trial of Navenibart for HAE